What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Cancer
Bob Löwenberg mainly investigates Internal medicine, Leukemia, Myeloid leukemia, Immunology and Myeloid.
Bob Löwenberg combines subjects such as Gastroenterology, Surgery and Oncology with his study of Internal medicine.
His work is dedicated to discovering how Oncology, Clinical trial are connected with Intensive care medicine and other disciplines.
His Leukemia study which covers Hazard ratio that intersects with Minimal residual disease.
His Myeloid leukemia study deals with the bigger picture of Cancer research.
His Immunology study combines topics from a wide range of disciplines, such as CD34, Haematopoiesis, Stem cell and Neutropenia.
His most cited work include:
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. (2438 citations)
- Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia (2097 citations)
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel (2002 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Myeloid leukemia, Leukemia, Immunology and Cancer research.
The study incorporates disciplines such as Gastroenterology, Surgery and Oncology in addition to Internal medicine.
His Oncology research is multidisciplinary, relying on both Minimal residual disease, NPM1, Cohort and Hazard ratio.
His Myeloid leukemia research is multidisciplinary, incorporating perspectives in Molecular biology, Gene, CEBPA and Gene expression profiling.
His work carried out in the field of Leukemia brings together such families of science as Myeloid, Cancer, Survival analysis and Acute promyelocytic leukemia.
His Immunology research integrates issues from Progenitor cell, Haematopoiesis and Stem cell.
He most often published in these fields:
- Internal medicine (42.46%)
- Myeloid leukemia (37.28%)
- Leukemia (27.07%)
What were the highlights of his more recent work (between 2013-2021)?
- Internal medicine (42.46%)
- Myeloid leukemia (37.28%)
- Oncology (21.01%)
In recent papers he was focusing on the following fields of study:
Bob Löwenberg mainly focuses on Internal medicine, Myeloid leukemia, Oncology, Leukemia and Cancer research.
His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Surgery.
His Myeloid leukemia study integrates concerns from other disciplines, such as Adverse effect, Bone marrow, Clinical trial and Immunotherapy.
The concepts of his Oncology study are interwoven with issues in Minimal residual disease, NPM1, Transplantation and Hazard ratio.
Leukemia is a primary field of his research addressed under Immunology.
His biological study spans a wide range of topics, including Survival rate and Haematopoiesis, Stem cell.
Between 2013 and 2021, his most popular works were:
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel (2002 citations)
- A Single Oncogenic Enhancer Rearrangement Causes Concomitant EVI1 and GATA2 Deregulation in Leukemia (383 citations)
- A 17-gene stemness score for rapid determination of risk in acute leukaemia (309 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
Bob Löwenberg mostly deals with Internal medicine, Leukemia, Myeloid leukemia, Oncology and Myeloid.
Much of his study explores Internal medicine relationship to Surgery.
The subject of his Leukemia research is within the realm of Immunology.
His research in Myeloid leukemia is mostly concerned with Interleukin-3 receptor.
The Oncology study combines topics in areas such as Cancer, Clinical trial, Minimal residual disease, Febrile neutropenia and Pharmacodynamics.
The various areas that he examines in his Myeloid study include DNA methylation, Mutation, Molecular biology, RUNX1 and Survival analysis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
